Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Eilsberger

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 30, 2020
Controversies in Radioiodine Treatment of Low- and Intermediate-risk Thyroid CancerF Eilsberger, F A Verburg
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|June 26, 2020
[Iodine-induced thyroid dysfunction]F Eilsberger, M Luster, J Feldkamp
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 13, 2023
Mutation-based, short-term "neoadjuvant" treatment allows resectability in stage IVB and C anaplastic thyroid cancerElisabeth Maurer, F Eilsberger, S Wächter, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 30, 2020
Controversies in Radioiodine Treatment of Low- and Intermediate-risk Thyroid CancerF Eilsberger, F A Verburg
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|June 26, 2020
[Iodine-induced thyroid dysfunction]F Eilsberger, M Luster, J Feldkamp
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 13, 2023
Mutation-based, short-term "neoadjuvant" treatment allows resectability in stage IVB and C anaplastic thyroid cancerElisabeth Maurer, F Eilsberger, S Wächter, et al.
Pageof 1